Time to reconsider the role of sentinel lymph node biopsy in melanoma

被引：23

作者：

Bigby, Michael ^{[1
,2
]}

Zagarella, Samuel ^{[3
]}

Sladden, Michael ^{[4
]}

Popescu, Catalin M. ^{[5
]}

机构：

[1] Harvard Med Sch, Dept Dermatol, Boston, MA 02215 USA

[2] Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA

[3] Univ Sydney, Dept Dermatol, Sch Med, Sydney, NSW, Australia

[4] Univ Tasmania, Dept Med, Sch Med, Launceston, Tas, Australia

[5] Carol Davila Univ Med & Pharm, Bucharest, Romania

来源：

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY | 2019年 / 80卷 / 04期

关键词：

Breslow thickness; hazard ration; immediate completion lymph node dissection; melanoma; multicenter selective lymphadenectomy trial; prognosis; sentinel lymph node biopsy; survival; PROGNOSTIC VALUE; SURVIVAL;

D O I：

10.1016/j.jaad.2018.11.026

中图分类号：

R75 [皮肤病学与性病学];

学科分类号：

100206 ;

摘要：

The Multicenter Selective Lymphadenectomy Trials indicate that there are no overall or melanoma-specific survival advantages to performing sentinel lymph node biopsy (SLNB) followed by immediate completion lymph node dissection compared with wide excision and observation for patients with positive sentinel nodes. These results make SLNB solely a staging procedure. The role of SLNB in the management of patients with melanoma deserves reappraisal. The potential marginal benefit of SLNB beyond the clinical and pathologic features of the melanoma has not been well studied. The use of sentinel lymph node status alone to accept and stratify patients into trials or to receive adjuvant treatment is not rational.

引用

页码：1168 / 1171

页数：4

共 50 条

[21] Vulvar melanoma - Is there a role for sentinel lymph node biopsy?
de Hullu, JA
Hollema, H
Hoekstra, HJ
Piers, DA
Mourits, MJE
Aalders, JG
van der Zee, AGJ
CANCER, 2002, 94 (02) : 486 - 491
[22] Patterns of recurrence after sentinel lymph node biopsy for cutaneous melanoma
Fincher, TR
McCarty, TM
Fisher, TL
Preskitt, JT
Lieberman, ZH
Stephens, JF
O'Brien, JC
Kuhn, JA
AMERICAN JOURNAL OF SURGERY, 2003, 186 (06): : 675 - 681
[23] Sentinel lymph node biopsy for cutaneous melanoma: A propos of 144 cases
Konofaos, Petros
Karypidis, Dimitrios
Chrisostomidis, Chrisostomos
Kostopoulos, Epaminondas
Champsas, Gregorios
Papadopoulos, Othon
JOURNAL OF BUON, 2014, 19 (01): : 263 - 272
[24] A critical reappraisal of false negative sentinel lymph node biopsy in melanoma
Manca, G.
Romanini, A.
Rubello, D.
Mazzarri, S.
Boni, G.
Chiacchio, S.
Tredici, M.
Duce, V.
Tardelli, E.
Volterrani, D.
Mariani, G.
QUARTERLY JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2014, 58 (02): : 105 - 113
[25] Survival benefit of sentinel lymph node biopsy in Asian melanoma patients
Hsu, Che-Chia
Liao, Yi-Hua
Sheen, Yi-Shuan
PIGMENT CELL & MELANOMA RESEARCH, 2023, 36 (06) : 522 - 530
[26] Underuse of sentinel lymph node biopsy for early-stage melanoma
Rajeh, Ahmad
Wan, Guihong
Roster, Katie
Rashdan, Hannah
Seo, Jaybyun
Nguyen, Nga
Collier, Michael R.
Leung, Bonnie W.
Semenov, Yevgeniy R.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2023, 89 (04) : 803 - 806
[27] Risk factors and patterns of recurrence after sentinel lymph node biopsy for thin melanoma
Kim, Daniel
Chu, Stanley
Khan, Ayesha U.
Compres, Elsy, V
Zhang, Hui
Gerami, Pedram
Wayne, Jeffrey D.
ARCHIVES OF DERMATOLOGICAL RESEARCH, 2022, 314 (03) : 285 - 292
[28] Prognostic value of sentinel lymph node biopsy according to Breslow thickness for cutaneous melanoma
Stiegel, Evan
Xiong, David
Ya, Jason
Funchain, Pauline
Isakov, Raymond
Gastman, Brian
Vij, Alok
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2018, 78 (05) : 942 - 948
[29] Risk factors and patterns of recurrence after sentinel lymph node biopsy for thin melanoma
Daniel Kim
Stanley Chu
Ayesha U. Khan
Elsy V. Compres
Hui Zhang
Pedram Gerami
Jeffrey D. Wayne
Archives of Dermatological Research, 2022, 314 : 285 - 292
[30] In Reply: Sentinel Lymph Node Biopsy in Melanoma
Leiter, Ulrike M. D.
Garbe, Claus M. D.
ANNALS OF SURGICAL ONCOLOGY, 2011, 18 (02) : 598 - 599

← 1 2 3 4 5 →